{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:55:48Z","timestamp":1789656948090,"version":"4.0.1"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1997,7]]},"DOI":"10.1212\/wnl.49.1.267","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:29:31Z","timestamp":1336915771000},"page":"267-270","source":"Crossref","is-referenced-by-count":135,"title":["Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas"],"prefix":"10.1212","volume":"49","author":[{"given":"David H.","family":"Gutmann","sequence":"first","affiliation":[{"name":"From The Departments of Neurology (Dr. Gutmann and Ms. Fishback) and Neurosurgery (Dr. Giordano), Washington University School of Medicine, St. Louis, MO, and The Lunenfeld Research Institute, Mt. Sinai Hospital and The Toronto Hospital, Division of Neurosurgery, Toronto, Ontario, CANADA (Dr. Guha)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Giordano","sequence":"additional","affiliation":[{"name":"From The Departments of Neurology (Dr. Gutmann and Ms. Fishback) and Neurosurgery (Dr. Giordano), Washington University School of Medicine, St. Louis, MO, and The Lunenfeld Research Institute, Mt. Sinai Hospital and The Toronto Hospital, Division of Neurosurgery, Toronto, Ontario, CANADA (Dr. Guha)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda S.","family":"Fishback","sequence":"additional","affiliation":[{"name":"From The Departments of Neurology (Dr. Gutmann and Ms. Fishback) and Neurosurgery (Dr. Giordano), Washington University School of Medicine, St. Louis, MO, and The Lunenfeld Research Institute, Mt. Sinai Hospital and The Toronto Hospital, Division of Neurosurgery, Toronto, Ontario, CANADA (Dr. Guha)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Guha","sequence":"additional","affiliation":[{"name":"From The Departments of Neurology (Dr. Gutmann and Ms. Fishback) and Neurosurgery (Dr. Giordano), Washington University School of Medicine, St. Louis, MO, and The Lunenfeld Research Institute, Mt. Sinai Hospital and The Toronto Hospital, Division of Neurosurgery, Toronto, Ontario, CANADA (Dr. Guha)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"5","volume":"363","year":"1993","unstructured":"Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993;363:515-521.","journal-title":"Nature"},{"key":"e_1_3_1_3_2","first-page":"1","volume":"72","year":"1993","unstructured":"Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993;72:1-20.","journal-title":"Cell"},{"key":"e_1_3_1_4_2","first-page":"2","volume":"5","year":"1992","unstructured":"Bijisma EK, Brouwer-Mladin R, Bosch DA, Westerveld A, Hulsebos TJM. Molecular characterization of chromosome 22 deletions in schwannomas. Genes Chromosom Cancer 1992;5:201-205.","journal-title":"Genes Chromosom Cancer"},{"key":"e_1_3_1_5_2","first-page":"2","volume":"13","year":"1995","unstructured":"Merel P, Hoang-Xuan K, Sanson M, et al. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chromosom Cancer 1995;13:211-216.","journal-title":"Genes Chromosom Cancer"},{"key":"e_1_3_1_6_2","first-page":"4","volume":"54","year":"1994","unstructured":"Rubio M-P, Correa KM, Ramesh V, et al. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res 1994;54:45-47.","journal-title":"Cancer Res"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0194-1"},{"key":"e_1_3_1_8_2","first-page":"1","volume":"3","year":"1994","unstructured":"Twist EC, Ruttledge MH, Rouseau M, et al. The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 1994;3:147-151.","journal-title":"Hum Mol Genet"},{"key":"e_1_3_1_9_2","first-page":"3","volume":"5","year":"1992","unstructured":"Ransom DT, Ritlans SR, Kimmel PJ, et al. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas and oligodendrogliomas. Genes Chromosom Cancer 1992;5:348-356.","journal-title":"Genes Chromosom Cancer"},{"key":"e_1_3_1_10_2","first-page":"5","volume":"46","year":"1996","unstructured":"Scherer SS, Gutmann DH. Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells. J Neurosci Res 1996;46:595-605.","journal-title":"J Neurosci Res"},{"key":"e_1_3_1_11_2","first-page":"8","volume":"3","year":"1994","unstructured":"Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst SM. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet 1994;3:885-891.","journal-title":"Hum Mol Genet"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.49.1.267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T15:48:18Z","timestamp":1711554498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.49.1.267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,7]]}},"alternative-id":["10.1212\/WNL.49.1.267"],"URL":"https:\/\/doi.org\/10.1212\/wnl.49.1.267","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,7]]}}}